Global Thrombin Market Research Report 2023

Global Thrombin Market Research Report 2023

Table of Contents
1 Thrombin Market Overview
1.1 Product Overview and Scope of Thrombin
1.2 Thrombin Segment by Type
1.2.1 Global Thrombin Market Value Comparison by Type (2023-2029)
1.2.2 Powder Form
1.2.3 Solution Form
1.2.4 Pad Form
1.2.5 Spray Kits
1.2.6 Others
1.3 Thrombin Segment by Application
1.3.1 Global Thrombin Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Diagnostics & Clinics
1.3.4 Academic and Research Institute
1.4 Global Thrombin Market Size Estimates and Forecasts
1.4.1 Global Thrombin Revenue 2018-2029
1.4.2 Global Thrombin Sales 2018-2029
1.4.3 Global Thrombin Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Thrombin Market Competition by Manufacturers
2.1 Global Thrombin Sales Market Share by Manufacturers (2018-2023)
2.2 Global Thrombin Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Thrombin Average Price by Manufacturers (2018-2023)
2.4 Global Thrombin Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Thrombin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Thrombin, Product Type & Application
2.7 Thrombin Market Competitive Situation and Trends
2.7.1 Thrombin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Thrombin Players Market Share by Revenue
2.7.3 Global Thrombin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Thrombin Retrospective Market Scenario by Region
3.1 Global Thrombin Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Thrombin Global Thrombin Sales by Region: 2018-2029
3.2.1 Global Thrombin Sales by Region: 2018-2023
3.2.2 Global Thrombin Sales by Region: 2024-2029
3.3 Global Thrombin Global Thrombin Revenue by Region: 2018-2029
3.3.1 Global Thrombin Revenue by Region: 2018-2023
3.3.2 Global Thrombin Revenue by Region: 2024-2029
3.4 North America Thrombin Market Facts & Figures by Country
3.4.1 North America Thrombin Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Thrombin Sales by Country (2018-2029)
3.4.3 North America Thrombin Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Thrombin Market Facts & Figures by Country
3.5.1 Europe Thrombin Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Thrombin Sales by Country (2018-2029)
3.5.3 Europe Thrombin Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Thrombin Market Facts & Figures by Country
3.6.1 Asia Pacific Thrombin Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Thrombin Sales by Country (2018-2029)
3.6.3 Asia Pacific Thrombin Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Thrombin Market Facts & Figures by Country
3.7.1 Latin America Thrombin Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Thrombin Sales by Country (2018-2029)
3.7.3 Latin America Thrombin Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Thrombin Market Facts & Figures by Country
3.8.1 Middle East and Africa Thrombin Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Thrombin Sales by Country (2018-2029)
3.8.3 Middle East and Africa Thrombin Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Thrombin Sales by Type (2018-2029)
4.1.1 Global Thrombin Sales by Type (2018-2023)
4.1.2 Global Thrombin Sales by Type (2024-2029)
4.1.3 Global Thrombin Sales Market Share by Type (2018-2029)
4.2 Global Thrombin Revenue by Type (2018-2029)
4.2.1 Global Thrombin Revenue by Type (2018-2023)
4.2.2 Global Thrombin Revenue by Type (2024-2029)
4.2.3 Global Thrombin Revenue Market Share by Type (2018-2029)
4.3 Global Thrombin Price by Type (2018-2029)
5 Segment by Application
5.1 Global Thrombin Sales by Application (2018-2029)
5.1.1 Global Thrombin Sales by Application (2018-2023)
5.1.2 Global Thrombin Sales by Application (2024-2029)
5.1.3 Global Thrombin Sales Market Share by Application (2018-2029)
5.2 Global Thrombin Revenue by Application (2018-2029)
5.2.1 Global Thrombin Revenue by Application (2018-2023)
5.2.2 Global Thrombin Revenue by Application (2024-2029)
5.2.3 Global Thrombin Revenue Market Share by Application (2018-2029)
5.3 Global Thrombin Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Thrombin Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Takeda Thrombin Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Thrombin Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bayer Thrombin Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 CSL
6.3.1 CSL Corporation Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Thrombin Sales, Revenue and Gross Margin (2018-2023)
6.3.4 CSL Thrombin Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Grifols
6.4.1 Grifols Corporation Information
6.4.2 Grifols Description and Business Overview
6.4.3 Grifols Thrombin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Grifols Thrombin Product Portfolio
6.4.5 Grifols Recent Developments/Updates
6.5 GE Healthcare
6.5.1 GE Healthcare Corporation Information
6.5.2 GE Healthcare Description and Business Overview
6.5.3 GE Healthcare Thrombin Sales, Revenue and Gross Margin (2018-2023)
6.5.4 GE Healthcare Thrombin Product Portfolio
6.5.5 GE Healthcare Recent Developments/Updates
6.6 Hualan Biological
6.6.1 Hualan Biological Corporation Information
6.6.2 Hualan Biological Description and Business Overview
6.6.3 Hualan Biological Thrombin Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hualan Biological Thrombin Product Portfolio
6.6.5 Hualan Biological Recent Developments/Updates
6.7 Haematologic Technologies Inc.
6.6.1 Haematologic Technologies Inc. Corporation Information
6.6.2 Haematologic Technologies Inc. Description and Business Overview
6.6.3 Haematologic Technologies Inc. Thrombin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Haematologic Technologies Inc. Thrombin Product Portfolio
6.7.5 Haematologic Technologies Inc. Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Thrombin Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Pfizer Thrombin Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Octapharma
6.9.1 Octapharma Corporation Information
6.9.2 Octapharma Description and Business Overview
6.9.3 Octapharma Thrombin Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Octapharma Thrombin Product Portfolio
6.9.5 Octapharma Recent Developments/Updates
6.10 Omrix Biopharmaceuticals Ltd.
6.10.1 Omrix Biopharmaceuticals Ltd. Corporation Information
6.10.2 Omrix Biopharmaceuticals Ltd. Description and Business Overview
6.10.3 Omrix Biopharmaceuticals Ltd. Thrombin Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Omrix Biopharmaceuticals Ltd. Thrombin Product Portfolio
6.10.5 Omrix Biopharmaceuticals Ltd. Recent Developments/Updates
6.11 Shanghai RAAS
6.11.1 Shanghai RAAS Corporation Information
6.11.2 Shanghai RAAS Thrombin Description and Business Overview
6.11.3 Shanghai RAAS Thrombin Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Shanghai RAAS Thrombin Product Portfolio
6.11.5 Shanghai RAAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Thrombin Industry Chain Analysis
7.2 Thrombin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Thrombin Production Mode & Process
7.4 Thrombin Sales and Marketing
7.4.1 Thrombin Sales Channels
7.4.2 Thrombin Distributors
7.5 Thrombin Customers
8 Thrombin Market Dynamics
8.1 Thrombin Industry Trends
8.2 Thrombin Market Drivers
8.3 Thrombin Market Challenges
8.4 Thrombin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Thrombin Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Thrombin Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Thrombin Market Competitive Situation by Manufacturers in 2022
Table 4. Global Thrombin Sales (MT) of Key Manufacturers (2018-2023)
Table 5. Global Thrombin Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Thrombin Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Thrombin Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Thrombin Average Price (USD/Kg) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Thrombin, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Thrombin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Thrombin, Product Type & Application
Table 12. Global Key Manufacturers of Thrombin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Thrombin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thrombin as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Thrombin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Thrombin Sales by Region (2018-2023) & (MT)
Table 18. Global Thrombin Sales Market Share by Region (2018-2023)
Table 19. Global Thrombin Sales by Region (2024-2029) & (MT)
Table 20. Global Thrombin Sales Market Share by Region (2024-2029)
Table 21. Global Thrombin Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Thrombin Revenue Market Share by Region (2018-2023)
Table 23. Global Thrombin Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Thrombin Revenue Market Share by Region (2024-2029)
Table 25. North America Thrombin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Thrombin Sales by Country (2018-2023) & (MT)
Table 27. North America Thrombin Sales by Country (2024-2029) & (MT)
Table 28. North America Thrombin Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Thrombin Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Thrombin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Thrombin Sales by Country (2018-2023) & (MT)
Table 32. Europe Thrombin Sales by Country (2024-2029) & (MT)
Table 33. Europe Thrombin Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Thrombin Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Thrombin Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Thrombin Sales by Region (2018-2023) & (MT)
Table 37. Asia Pacific Thrombin Sales by Region (2024-2029) & (MT)
Table 38. Asia Pacific Thrombin Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Thrombin Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Thrombin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Thrombin Sales by Country (2018-2023) & (MT)
Table 42. Latin America Thrombin Sales by Country (2024-2029) & (MT)
Table 43. Latin America Thrombin Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Thrombin Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Thrombin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Thrombin Sales by Country (2018-2023) & (MT)
Table 47. Middle East & Africa Thrombin Sales by Country (2024-2029) & (MT)
Table 48. Middle East & Africa Thrombin Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Thrombin Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Thrombin Sales (MT) by Type (2018-2023)
Table 51. Global Thrombin Sales (MT) by Type (2024-2029)
Table 52. Global Thrombin Sales Market Share by Type (2018-2023)
Table 53. Global Thrombin Sales Market Share by Type (2024-2029)
Table 54. Global Thrombin Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Thrombin Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Thrombin Revenue Market Share by Type (2018-2023)
Table 57. Global Thrombin Revenue Market Share by Type (2024-2029)
Table 58. Global Thrombin Price (USD/Kg) by Type (2018-2023)
Table 59. Global Thrombin Price (USD/Kg) by Type (2024-2029)
Table 60. Global Thrombin Sales (MT) by Application (2018-2023)
Table 61. Global Thrombin Sales (MT) by Application (2024-2029)
Table 62. Global Thrombin Sales Market Share by Application (2018-2023)
Table 63. Global Thrombin Sales Market Share by Application (2024-2029)
Table 64. Global Thrombin Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Thrombin Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Thrombin Revenue Market Share by Application (2018-2023)
Table 67. Global Thrombin Revenue Market Share by Application (2024-2029)
Table 68. Global Thrombin Price (USD/Kg) by Application (2018-2023)
Table 69. Global Thrombin Price (USD/Kg) by Application (2024-2029)
Table 70. Takeda Corporation Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 73. Takeda Thrombin Product
Table 74. Takeda Recent Developments/Updates
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 78. Bayer Thrombin Product
Table 79. Bayer Recent Developments/Updates
Table 80. CSL Corporation Information
Table 81. CSL Description and Business Overview
Table 82. CSL Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 83. CSL Thrombin Product
Table 84. CSL Recent Developments/Updates
Table 85. Grifols Corporation Information
Table 86. Grifols Description and Business Overview
Table 87. Grifols Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 88. Grifols Thrombin Product
Table 89. Grifols Recent Developments/Updates
Table 90. GE Healthcare Corporation Information
Table 91. GE Healthcare Description and Business Overview
Table 92. GE Healthcare Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 93. GE Healthcare Thrombin Product
Table 94. GE Healthcare Recent Developments/Updates
Table 95. Hualan Biological Corporation Information
Table 96. Hualan Biological Description and Business Overview
Table 97. Hualan Biological Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 98. Hualan Biological Thrombin Product
Table 99. Hualan Biological Recent Developments/Updates
Table 100. Haematologic Technologies Inc. Corporation Information
Table 101. Haematologic Technologies Inc. Description and Business Overview
Table 102. Haematologic Technologies Inc. Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 103. Haematologic Technologies Inc. Thrombin Product
Table 104. Haematologic Technologies Inc. Recent Developments/Updates
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 108. Pfizer Thrombin Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Octapharma Corporation Information
Table 111. Octapharma Description and Business Overview
Table 112. Octapharma Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 113. Octapharma Thrombin Product
Table 114. Octapharma Recent Developments/Updates
Table 115. Omrix Biopharmaceuticals Ltd. Corporation Information
Table 116. Omrix Biopharmaceuticals Ltd. Description and Business Overview
Table 117. Omrix Biopharmaceuticals Ltd. Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 118. Omrix Biopharmaceuticals Ltd. Thrombin Product
Table 119. Omrix Biopharmaceuticals Ltd. Recent Developments/Updates
Table 120. Shanghai RAAS Corporation Information
Table 121. Shanghai RAAS Description and Business Overview
Table 122. Shanghai RAAS Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 123. Shanghai RAAS Thrombin Product
Table 124. Shanghai RAAS Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Thrombin Distributors List
Table 128. Thrombin Customers List
Table 129. Thrombin Market Trends
Table 130. Thrombin Market Drivers
Table 131. Thrombin Market Challenges
Table 132. Thrombin Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Thrombin
Figure 2. Global Thrombin Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Thrombin Market Share by Type in 2022 & 2029
Figure 4. Powder Form Product Picture
Figure 5. Solution Form Product Picture
Figure 6. Pad Form Product Picture
Figure 7. Spray Kits Product Picture
Figure 8. Others Product Picture
Figure 9. Global Thrombin Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Thrombin Market Share by Application in 2022 & 2029
Figure 11. Hospitals
Figure 12. Diagnostics & Clinics
Figure 13. Academic and Research Institute
Figure 14. Global Thrombin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Thrombin Market Size (2018-2029) & (US$ Million)
Figure 16. Global Thrombin Sales (2018-2029) & (MT)
Figure 17. Global Thrombin Average Price (USD/Kg) & (2018-2029)
Figure 18. Thrombin Report Years Considered
Figure 19. Thrombin Sales Share by Manufacturers in 2022
Figure 20. Global Thrombin Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Thrombin Players: Market Share by Revenue in 2022
Figure 22. Thrombin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Thrombin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Thrombin Sales Market Share by Country (2018-2029)
Figure 25. North America Thrombin Revenue Market Share by Country (2018-2029)
Figure 26. the United States Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Thrombin Sales Market Share by Country (2018-2029)
Figure 29. Europe Thrombin Revenue Market Share by Country (2018-2029)
Figure 30. Germany Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. UK Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Thrombin Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Thrombin Revenue Market Share by Region (2018-2029)
Figure 37. China Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Thrombin Sales Market Share by Country (2018-2029)
Figure 47. Latin America Thrombin Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Thrombin Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Thrombin Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Thrombin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Thrombin by Type (2018-2029)
Figure 57. Global Revenue Market Share of Thrombin by Type (2018-2029)
Figure 58. Global Thrombin Price (USD/Kg) by Type (2018-2029)
Figure 59. Global Sales Market Share of Thrombin by Application (2018-2029)
Figure 60. Global Revenue Market Share of Thrombin by Application (2018-2029)
Figure 61. Global Thrombin Price (USD/Kg) by Application (2018-2029)
Figure 62. Thrombin Value Chain
Figure 63. Thrombin Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Hemophilia A Drug Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 23-May-2023        Price: US 3260 Onwards        Pages: 118

Factor VIII procoagulant component (VIII: C) deficiency, also known as AGH deficiency, is a sexually associated recessive genetic disease, transmitted by women, and male. The Hemophilia A Drug market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Hemophilia A Drug industry, and breaks down according to the type, applicatio......

Global Deep Vein Thrombosis (DVT) Drug Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 23-May-2023        Price: US 3260 Onwards        Pages: 97

The Deep Vein Thrombosis (DVT) Drug market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Deep Vein Thrombosis (DVT) Drug industry, and breaks down according to the type, application, and consumption area of Deep Vein Thrombosis (DVT) Drug. The report also introduces players in the industry from the perspective of the industry ch......

Global Intravenous Immunoglobulin (IVIg) Market Size, Share and Industry Analysis by Regions, Countries, Types, and Applications, Forecast to 2028

Published: 19-May-2023        Price: US 3480 Onwards        Pages: 114

The global Intravenous Immunoglobulin (IVIg) market size was valued at USD 13315.76 Million in 2022 and will reach USD 24771.66 Million in 2028, with a CAGR of 10.9% during 2022-2028. Intravenous Immunoglobulin (IVIG) is a solution of highly purified Immunoglobulin G, derived from large pools of human plasma that contain antibodies against a broad spectrum of bacterial and viral agents. Influence of COVID-19 Outbreak on Intravenous Immunoglobulin (IVIg) Industry Deve......

Global Intravenous Immunoglobulin Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 18-May-2023        Price: US 3260 Onwards        Pages: 106

Intravenous immune globulin (IVIG) is a product prepared from human plasma used to treat a variety of immunodeficiency and autoimmune conditions. The Intravenous Immunoglobulin market revenue was 12435.3 Million USD in 2022, and will reach 19485.47 Million USD in 2028, with a CAGR of 7.77% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Intravenous Immunoglobulin industry, and breaks down according to the type, appl......

2023-2031 Report on Global Anticoagulants Market by Player, Region, Type, Application and Sales Channel

Published: 24-Apr-2023        Price: US 2500 Onwards        Pages: 103

This report studies the Anticoagulants market, covering market size for segment by type (Platelet aggregation inhibitors (PAI), Low-molecular-weight Heparin (LMWH), etc.), by application (VTE, ACS/MI, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Sanofi, Bayer, Boehringer Ingelheim, Johnson & Johnson, Genentech (Roche), etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed histo......

2023-2031 Report on Global Low Molecular Weight Heparin Market by Player, Region, Type, Application and Sales Channel

Published: 24-Apr-2023        Price: US 2500 Onwards        Pages: 92

This report studies the Low Molecular Weight Heparin market, covering market size for segment by type (Enoxaparin, Dalteparin, etc.), by application (Treatment of Venous Thromboembolism, Complications of Pregnancy, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis......

Global Heparin Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 13-Apr-2023        Price: US 3260 Onwards        Pages: 121

The Heparin market revenue was 7285.21 Million USD in 2022, and will reach 8765.54 Million USD in 2028, with a CAGR of 3.13% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Heparin industry, and breaks down according to the type, application, and consumption area of Heparin. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.......

Global Fibrinogen Concentrates Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 06-Apr-2023        Price: US 3260 Onwards        Pages: 107

Fibrinogen, also known as coagulation factor I, is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen deficiency is a rare bleeding disorder characterized by mild to severe form of bleeding. The three types for fibrinogen deficiencies are: afibrinogenemia, hypofibrogenemia, and dysfibrinogenemia. In severely bleeding patients, fibrinogen concentrate significantly improves whole blood clot firmness and reduces the postoperative transfusion requirements. Currently......

2023-2031 Report on Global Intravenous Immunoglobulin Market by Player, Region, Type, Application and Sales Channel

Published: 04-Apr-2023        Price: US 2500 Onwards        Pages: 100

This report studies the Intravenous Immunoglobulin market, covering market size for segment by type (IVIg Liquid, IVIg Powder, etc.), by application (Immunodeficiency, Autoimmune Disease, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Baxter, Grifols, CSL, Octapharma, Biotest, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Intraveno......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs